Targeted HIV drug resistance testing moves into routine care in South Africa
Researchers at Wits University, South Africa's National Health Laboratory Service (NHLS) and University Medical Center Utrecht have developed a new way to help people whose HIV viral load increased while they were taking the highly effective standard antiretroviral treatment dolutegravir (DTG).
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.